Now accepting applications for the 2020 BIO Investor Forum.

Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, genomics, digital health or platform technologies. Service providers will not be considered. For questions about company presentations, please read our FAQ here.

Presenting company classifications include:

BIOTECH/PHARMA COMPANY:  Corporations or other entities that use biotechnology or related technologies for research and development of products or information.

DISCOVERY TRACK COMPANY:  Corporations qualifying for the Discovery Track rates include only the following: Discovery Track corporations are "pre-emerging" biotech companies, qualifying as seed and A-round companies that have raised since founding less than $9M total through October 2019. For this event, Discovery Track companies must use biotechnology or related technologies to conduct or support research and development of drug products, diagnostics, or digital therapeutics intended for regulatory approval or already under regulatory review.

EMERGING INNOVATORS TRACK COMPANY (NEW):  Corporations qualifying for the Emerging Innovators Track rates include only the following: Emerging Innovators Track corporations are biotech companies that have cumulatively raised at least $9M, but less than $25M total through October 2019. For this event, Emerging Innovator Track companies must use biotechnology or related technologies to conduct or support research and development of drug products, diagnostics, or digital therapeutics intended for regulatory approval or already under regulatory review.  

 Apply Here

Learn best practices on how to refine your presentation deck and pitch to partners. Download our series of short biotech-focused video lessons.